Key stats
About CMF CSI Biotechnology Thematic Exchange Traded Fund Units
Home page
Inception date
Feb 8, 2021
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
China Merchants Fund Management Co., Ltd.
ISIN
CNE100004GN7
Tightly track the target index, pursue the minimization of tracking deviation and tracking err.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks97.12%
Health Technology92.02%
Commercial Services1.90%
Transportation1.12%
Producer Manufacturing0.83%
Health Services0.66%
Distribution Services0.59%
Bonds, Cash & Other2.88%
Cash2.88%
Stock breakdown by region
Asia97.69%
Europe2.31%
North America0.00%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
159849 invests in stocks. The fund's major sectors are Health Technology, with 92.02% stocks, and Commercial Services, with 1.90% of the basket. The assets are mostly located in the Asia region.
159849 top holdings are Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A and Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A, occupying 10.06% and 9.77% of the portfolio correspondingly.
No, 159849 doesn't pay dividends to its holders.
159849 shares are issued by China Merchants Bank Co., Ltd. under the brand China Merchants. The ETF was launched on Feb 8, 2021, and its management style is Passive.
159849 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
159849 follows the CSI Biotechnology Theme Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159849 invests in stocks.